Spectrum of pulmonary side-effects of nivolumab – retrospective analysis
Autor: | Ip, Joana |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: | |
DOI: | 10.1594/ecr2018/c-0282 |
Popis: | Learning objectives Background Findings and procedure details Conclusion Personal information References Learning objectives: Nivolumab is a monoclonal antibody (anti PD-1) approvedfor the treatment of advanced melanoma, advanced non-small cell lung cancer (NSCLC), advanced renal cell carcinoma, classical Hodgkin lymphoma, advanced squamous cell carcinoma of the head and... |
Databáze: | OpenAIRE |
Externí odkaz: |